Foot and Ankle

Repair. Reinforce. Restore.

Whether you're reconstructing post-trauma, managing chronic wounds, or supporting delicate closures, your patients depend on optimal healing. That’s why we’ve developed a full portfolio of regenerative solutions designed to meet the demands of plastic and reconstructive surgery. We combine biological integrity, ease of use, and real-world versatility. From cryopreserved membranes to shelf-stable grafts, our products offer flexible options to support soft tissue regeneration across a wide range of procedures and patient profiles.

 

arrow

Tissue compatibility

Products that preserve native tissue composition, supporting host integration and natural healing.

 

arrow

Surgical flexibility

Conformable, easy-to-handle materials for a variety of anatomical locations, including exposed bone, tendon, and hardware.

 

arrow

Wound protection

Barrier properties and extracellular matrix (ECM) support to help reduce complications in at-risk or compromised sites.

 

arrow

Convenient formats

Cryopreserved and room-temperature storage options to fit your workflow.

 

arrow

Clinical performance

Supports revascularization, granulation, and epithelialization in acute and chronic cases.

Performance across the Plastic Surgery spectrum

 

STRAVIX◊ Tissue

STRAVIX◊ Tissue

Cryopreserved placental tissue

Rich in native matrix, growth factors, and viable cells; ideal for complex wounds and soft tissue repair

Learn more

STRAVIX application video thumbnail

STRAVIX PL application with Achilles tendon repair

Watch video

STRAVIX application video thumbnail

STRAVIX Meshed application with leg ulcer repair

Watch video

Related technologies

 

GRAFIX membranes thumbnail

GRAFIX PL◊ + GRAFIX◊ Placental Membranes

Learn more

OASIS thumbnail

OASIS◊ Matric products

Learn more

  1. Dhall S, Coksaygan T, Hoffman T, et al. Viable cryopreserved umbilical tissue (vCUT) reduces post-operative adhesions in a rabbit abdominal adhesion model. Bioact Mater. 2018; 4(1): 97-106.
  2. Data on file at Osiris Therapeutics, Inc.